Welcome to our consulting company Consultio!
ScieGen PharmaceuticalsScieGen PharmaceuticalsScieGen Pharmaceuticals
Call Us
New York 11788

News & Announcements

  • Home
  • News & Announcements

1

Aug 22

Received ANDA Approval for Pirfenidone Tablets, 267 mg and 801 mg.
Read More

1

Aug 22

Received ANDA Approval for Pirfenidone Capsules, 267 mg.
Read More

17

Mar 22

Received ANDA Approval for Lacosamide Tablets, USP 50 mg, 100 mg, 150 mg and 200 mg
Read More

22

Feb 22

Received ANDA Approval for Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 1000 mg
Read More

27

Oct 21

Received ANDA Approval for Valsartan Tablets USP, 40 mg, 80 mg, 160 mg, and 320 mg.
Read More

27

Oct 21

Quetiapine XR Tablets ANDA filed (ANDA 209635) by ScieGen is fully reviewed by FDA and approved on November 29, 2017.

From 2017 ScieGen is producing this product and distributed into the market.

During this period we never received any complaints from the customers on any adverse events and side effects. ScieGen performed Bioequivalence studies at Synchron (a Contract Research organization, who performs the Bioavailability and Bioequivalence studies).

Very recently FDA found some data integrity issues at Synchron. The issues observed at Synchron are not related to ScieGen’s product. As precautionary measure FDA asked all ANDA holders who performed their respective BE studies at Synchron for last 10 years to repeat the Biostudies and submit the data with a agency with 12 months. As part of this FDA decided to change status of all ANDA holders to “BX”, accordingly Sciegen’s product rating changed. FDA not asked us to recall the product. FDA has stated in its press release and webpage that “FDA has been conducting an investigation of postmarket safety reports for marketing applications that relied on bioequivalence studies conducted by Synchron or Panexcell for approval. To date, the agency has not identified signals related to problems with the safety or quality of the approved drugs. FDA remains vigilant and if the agency finds safety issues, we will take action and provide the latest information as appropriate. Patients should not make changes to their treatment except in consultation with their health care professional.”

ScieGen is planned to perform the BE studies, and will submit the data to agency by May’2022.

Please visit the FDA webpage

https://www.fda.gov/drugs/drug-safety-and-availability/notification-pharmaceutical-companies-clinical-and-bioanalytical-studies-conducted-panexcell
Read More

5

Oct 21

Received ANDA Approval for Carbidopa and Levodopa Extended-Release Tablets, 25 mg/100 mg and 50 mg/200 mg.
Read More

11

Jun 21

Received original ANDA Approval for Levetiracetam Tablets, USP 750 mg and 1000 mg.
Read More

7

May 21

Received ANDA Approval for Carbidopa and Levodopa Tablets, USP 10mg/100 mg, 25 mg/100 mg and 25 mg/250 mg.
Read More

16

Apr 21

ScieGen receives approval for Metformin ER tablets 500 mg and 1000 mg [ RLD , Glumetza ]
ScieGen Metformin ER tablets 500 mg and 1000 mg complying to FDA requirements of NDMA content less 96 nanograms (0.0376 ppm).
NDMA testing with a validated test method is a part of release and stability testing in Metformin ER tablets manufactured by ScieGen.
Read More
1 2 3

News / Announcements

1

Aug 22

Received ANDA Approval for Pirfenidone Tablets, 267 mg and 801 mg.
Read More

1

Aug 22

Received ANDA Approval for Pirfenidone Capsules, 267 mg.
Read More

17

Mar 22

Received ANDA Approval for Lacosamide Tablets, USP 50 mg, 100 mg, 150 mg and 200 mg
Read More

22

Feb 22

Received ANDA Approval for Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 1000 mg
Read More

27

Oct 21

Received ANDA Approval for Valsartan Tablets USP, 40 mg, 80 mg, 160 mg, and 320 mg.
Read More

27

Oct 21

Quetiapine XR Tablets ANDA filed (ANDA 209635) by ScieGen is fully reviewed by FDA and approved on November 29, 2017.

From 2017 ScieGen is producing this product and distributed into the market.

During this period we never received any complaints from the customers on any adverse events and side effects. ScieGen performed Bioequivalence studies at Synchron (a Contract Research organization, who performs the Bioavailability and Bioequivalence studies).

Very recently FDA found some data integrity issues at Synchron. The issues observed at Synchron are not related to ScieGen’s product. As precautionary measure FDA asked all ANDA holders who performed their respective BE studies at Synchron for last 10 years to repeat the Biostudies and submit the data with a agency with 12 months. As part of this FDA decided to change status of all ANDA holders to “BX”, accordingly Sciegen’s product rating changed. FDA not asked us to recall the product. FDA has stated in its press release and webpage that “FDA has been conducting an investigation of postmarket safety reports for marketing applications that relied on bioequivalence studies conducted by Synchron or Panexcell for approval. To date, the agency has not identified signals related to problems with the safety or quality of the approved drugs. FDA remains vigilant and if the agency finds safety issues, we will take action and provide the latest information as appropriate. Patients should not make changes to their treatment except in consultation with their health care professional.”

ScieGen is planned to perform the BE studies, and will submit the data to agency by May’2022.

Please visit the FDA webpage

https://www.fda.gov/drugs/drug-safety-and-availability/notification-pharmaceutical-companies-clinical-and-bioanalytical-studies-conducted-panexcell
Read More

5

Oct 21

Received ANDA Approval for Carbidopa and Levodopa Extended-Release Tablets, 25 mg/100 mg and 50 mg/200 mg.
Read More

11

Jun 21

Received original ANDA Approval for Levetiracetam Tablets, USP 750 mg and 1000 mg.
Read More

7

May 21

Received ANDA Approval for Carbidopa and Levodopa Tablets, USP 10mg/100 mg, 25 mg/100 mg and 25 mg/250 mg.
Read More

16

Apr 21

ScieGen receives approval for Metformin ER tablets 500 mg and 1000 mg [ RLD , Glumetza ]
ScieGen Metformin ER tablets 500 mg and 1000 mg complying to FDA requirements of NDMA content less 96 nanograms (0.0376 ppm).
NDMA testing with a validated test method is a part of release and stability testing in Metformin ER tablets manufactured by ScieGen.
Read More
1 2 3

At vero eos et accusamus et iusto odio digni goikussimos ducimus qui to bonfo blanditiis praese. Ntium voluum deleniti atque.

Melbourne, Australia
(Sat - Thursday)
(10am - 05 pm)

Metformin Hydrochloride Extended-Release Tablets, USP

NDC 50228-0503-60
Strength 500 mg
Description of pill White to off white, oval shape, film coated tablets, debossed with “503” on one side and plain on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Fortamet®
TE Code AB

Gabapentin Tablets, USP

NDC 50228-178-05
Strength 800 mg
Description of pill White to off white, Modified Capsule shape, biconvex tablets debossed SG on one side and 178 on other side with bisect line on both sides.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-105-01
Strength 500 mg
Description of pill White to off white, round, biconvex, beveled edge tablets debossed with "SG" on one side and "l05"on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Levocetirizine Dihydrochloride Tablets, USP

NDC 50228-136-90
Strength 5 mg
Description of pill White to off white, oval shaped, biconvex tablets de-bossed with S on the left side of bisect and G on the right side of bisect and other side '1' on the left side and 36 on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Anti-histamine
Brand Name Reference Xyzal®
TE Code AB

Levocetirizine Dihydrochloride Tablets, USP

NDC 50228-136-30
Strength 5 mg
Description of pill White to off white, oval shaped, biconvex tablets de-bossed with S on the left side of bisect and G on the right side of bisect and other side '1' on the left side and 36 on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Anti-histamine
Brand Name Reference Xyzal®
TE Code AB

Hydrochlorothiazide Capsules, USP

NDC 50228-146-10
Strength 12.5 mg
Description of pill White to off-White powder filled in Size '4' Hard Gelatin Capsules with Opaque light blue colored cap and Opaque light colored body imprinted 'SG' on cap and '146' on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-Hypertensive
Brand Name Reference Microzide®
TE Code AB

Hydrochlorothiazide Capsules, USP

NDC 50228-146-05
Strength 12.5 mg
Description of pill White to off-White powder filled in Size '4' Hard Gelatin Capsules with Opaque light blue colored cap and Opaque light colored body imprinted 'SG' on cap and '146' on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-Hypertensive
Brand Name Reference Microzide®
TE Code AB

Hydrochlorothiazide Capsules, USP

NDC 50228-146-01
Strength 12.5 mg
Description of pill White to off-White powder filled in Size '4' Hard Gelatin Capsules with Opaque light blue colored cap and Opaque light colored body imprinted 'SG' on cap and '146' on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-Hypertensive
Brand Name Reference Microzide®
TE Code AB

Gabapentin Tablets, USP

NDC 50228-178-01
Strength 800 mg
Description of pill White to off white, Modified Capsule shape, biconvex tablets debossed SG on one side and 178 on other side with bisect line on both sides.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-105-10
Strength 500 mg
Description of pill White to off white, round, biconvex, beveled edge tablets debossed with "SG" on one side and "l05"on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Gabapentin Tablets, USP

NDC 50228-177-05
Strength 600 mg
Description of pill White to off white, Modified Capsule shape, biconvex tablets debossed SG on one side and 177 on other side with bisect line on both sides
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Tablets, USP

NDC 50228-177-01
Strength 600 mg
Description of pill White to off white, Modified Capsule shape, biconvex tablets debossed SG on one side and 177 on other side with bisect line on both sides
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-181-05
Strength 400 mg
Description of pill White to Off white powder filled in size “0” hard gelatin capsules with opaque Orange colored cap and opaque Orange colored body imprinted “SG” on cap and “181” on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-181-01
Strength 400 mg
Description of pill White to Off white powder filled in size “0” hard gelatin capsules with opaque Orange colored cap and opaque Orange colored body imprinted “SG” on cap and “181” on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-180-05
Strength 300 mg
Description of pill White to off white powder filled in size “1” hard gelatin capsules with opaque Yellow colored cap and opaque Yellow colored body imprinted “SG” on cap and “180” on body with black ink
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-180-01
Strength 300 mg
Description of pill White to off white powder filled in size “1” hard gelatin capsules with opaque Yellow colored cap and opaque Yellow colored body imprinted “SG” on cap and “180” on body with black ink
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-179-05
Strength 100 mg
Description of pill White to Off white powder filled in size “3” hard gelatin capsules with opaque White colored cap and opaque White colored body imprinted “SG” on cap and “179” on body with black ink
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-105-05
Strength 500 mg
Description of pill White to off white, round, biconvex, beveled edge tablets debossed with "SG" on one side and "l05"on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-106-01
Strength 850 mg
Description of pill White to off white, round, biconvex, beveled edge tablets debossed w'ith' 'SG' on one side and "106"on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Fluoxetine Tablets, USP

NDC 50228-421-01
Strength 20 mg
Description of pill White Modified oval shape scored tablets debossed with 'SG' on scored side and "421" on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-depressant
Brand Name Reference Prozac
TE Code AB

Naproxen Tablets, USP

NDC 50228-434-01
Strength 250 mg
Description of pill Light Yellow round shaped tablets debossed with ''SG'' along with break-line on one side and ''434'' on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Naprosyn®
TE Code AB

Naproxen Sodium Tablets, USP

NDC 50228-433-01
Strength 550 mg (EQ 500 mg base)
Description of pill White, capsule shaped, film coated tablets, debossed with '433' on one side and 'SG' along with break line on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Anaprox DS®
TE Code AB

Naproxen Sodium Tablets, USP

NDC 50228-432-01
Strength 275 mg (EQ 250 mg base)
Description of pill White, capsule shaped, film coated tablets, debossed with '432' on one side and 'SG' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Anaprox®
TE Code AB

Naproxen Tablets, USP

NDC 50228-436-05
Strength 500 mg
Description of pill Light Yellow Oblong shaped tablets debossed with ''SG'' along with break-line on one side and ''436'' on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Naprosyn®
TE Code AB

Naproxen Tablets, USP

NDC 50228-436-01
Strength 500 mg
Description of pill Light Yellow Oblong shaped tablets debossed with ''SG'' along with break-line on one side and ''436'' on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Naprosyn®
TE Code AB

Naproxen Tablets, USP

NDC 50228-435-05
Strength 375 mg
Description of pill Light Yellow Capsule shaped tablets debossed with ''SG'' on one side and ''435'' on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Naprosyn®
TE Code AB

Naproxen Tablets, USP

NDC 50228-435-01
Strength 375 mg
Description of pill Light Yellow Capsule shaped tablets debossed with ''SG'' on one side and ''435'' on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Naprosyn®
TE Code AB

Naproxen Tablets, USP

NDC 50228-434-05
Strength 250 mg
Description of pill Light Yellow round shaped tablets debossed with ''SG'' along with break-line on one side and ''434'' on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Naprosyn®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-106-05
Strength 850 mg
Description of pill White to off white, round, biconvex, beveled edge tablets debossed w'ith' 'SG' on one side and "106"on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Nabumetone Tablets, USP

NDC 50228-466-05
Strength 750 mg
Description of pill White colored, Oval shaped, Biconvex, film coated tablets, debossed with ‘SG’ on one side ‘466’ on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Relafen®
TE Code AB

Nabumetone Tablets, USP

NDC 50228-466-01
Strength 750 mg
Description of pill White colored, Oval shaped, Biconvex, film coated tablets, debossed with ‘SG’ on one side ‘466’ on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Relafen®
TE Code AB

Nabumetone Tablets, USP

NDC 50228-465-05
Strength 500 mg
Description of pill White colored, Oval shaped, Biconvex, film coated tablets, debossed with ‘SG’ on one side ‘465’ on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Relafen®
TE Code AB

Nabumetone Tablets, USP

NDC 50228-465-01
Strength 500 mg
Description of pill White colored, Oval shaped, Biconvex, film coated tablets, debossed with ‘SG’ on one side ‘465’ on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Relafen®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-107-10
Strength 1000 mg
Description of pill White to off white, oval shaped, biconvex tablets debossed with S on the left side of bisect and G on the right side of bisect and other side 1 on the left side and 07 on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-107-05
Strength 1000 mg
Description of pill White to off white, oval shaped, biconvex tablets debossed with S on the left side of bisect and G on the right side of bisect and other side 1 on the left side and 07 on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-107-01
Strength 1000 mg
Description of pill White to off white, oval shaped, biconvex tablets debossed with S on the left side of bisect and G on the right side of bisect and other side 1 on the left side and 07 on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-179-01
Strength 100 mg
Description of pill White to Off white powder filled in size “3” hard gelatin capsules with opaque White colored cap and opaque White colored body imprinted “SG” on cap and “179” on body with black ink
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Fluoxetine Tablets, USP

NDC 50228-422-30
Strength 60 mg
Description of pill White to off white, Capsule shape film coated tablet with scored line on both sides debossed with “SG 422” on one side and plain on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-depressant
Brand Name Reference Fluoxetine HCl by Alvogen
TE Code AB

Pregabalin Capsules

NDC 50228-350-90
Strength 25 mg
Description of pill White to Off white powder filled in size "4" hard gelatin capsules with white opaque colored cap and white opaque colored body imprinted with "SG" on cap and "350" on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anticonvulsant/Analgesics/Fibromyalgia
Brand Name Reference Lyrica®
TE Code AB

Atorvastatin Calcium Tablets 80mg

NDC 50228-454-90
Strength 80 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and 155 on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-144-30
Strength 150 mg
Description of pill White to pale yellow, round, biconvex, film coated tablets, debossed with'144'on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin XL®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-175-05
Strength 150 mg
Description of pill Purple , round, biconvex tablets, debossed with 'SG 175' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin SR®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-175-05
Strength 150 mg
Description of pill Purple , round, biconvex tablets, debossed with 'SG 175' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin SR®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-174-05
Strength 100 mg
Description of pill Blue, round, biconvex, film coated tablets, debossed with 'SG, 174' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin SR®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-174-01
Strength 100 mg
Description of pill Blue, round, biconvex, film coated tablets, debossed with 'SG, 174' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin SR®
TE Code AB

Atorvastatin Calcium Tablets 80mg

NDC 50228-454-05
Strength 80 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and 155 on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Atorvastatin Calcium Tablets 40mg

NDC 50228-453-10
Strength 40 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and 154 on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-145-30
Strength 300 mg
Description of pill White to pale yellow, Modified Capsule Shape, biconvex, film coated tablets, debossed with 145' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin XL®
TE Code AB

Atorvastatin Calcium Tablets 40mg

NDC 50228-453-90
Strength 40 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and 154 on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Atorvastatin Calcium Tablets 20mg

NDC 50228-0452-05
Strength 20 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and 153 on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Atorvastatin Calcium Tablets 20mg

NDC 50228-452-90
Strength 20 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and 153 on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Atorvastatin Calcium Tablets 10mg

NDC 50228-451-10
Strength 10 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and '152' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Atorvastatin Calcium Tablets 10mg

NDC 50228-451-90
Strength 10 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and '152' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-176-60
Strength 200 mg
Description of pill Pink, round, biconvex, film coated tablets, debossed with oSG, 176' onone side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin SR®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-175-60
Strength 150 mg
Description of pill Purple , round, biconvex tablets, debossed with 'SG 175' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin SR®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-144-05
Strength 150 mg
Description of pill White to pale yellow, round, biconvex, film coated tablets, debossed with'144'on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin XL®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-145-05
Strength 300 mg
Description of pill White to pale yellow, Modified Capsule Shape, biconvex, film coated tablets, debossed with 145' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin XL®
TE Code AB

Fluoxetine Tablets, USP

NDC 50228-421-30
Strength 20 mg
Description of pill White Modified oval shape scored tablets debossed with 'SG' on scored side and "421" on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-depressant
Brand Name Reference Prozac
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-113-10
Strength 10 mg
Description of pill White to Off white powder filled in Empty Hard Gelatin Capsule Size 4, Opaque Light Blue Colored Cap and Opaque Light Orange Colored Body imprinted with "SG" on Cap and "113" on Body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Fluoxetine Tablets, USP

NDC 50228-420-01
Strength 10 mg
Description of pill White Modified oval shape scored tablets debossed with 'SG' on scored side and "420" on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-depressant
Brand Name Reference Prozac
TE Code AB

Fluoxetine Tablets, USP

NDC 50228-420-30
Strength 10 mg
Description of pill White Modified oval shape scored tablets debossed with 'SG' on scored side and "420" on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-depressant
Brand Name Reference Prozac
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-115-10
Strength 40 mg
Description of pill White to Off white powder filled in Hard Gelatin Capsules Size "0" with Opaque light blue colored cap and Opaque white colored body imprinted "SG" on cap and "115" on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-115-01
Strength 40 mg
Description of pill White to Off white powder filled in Hard Gelatin Capsules Size "0" with Opaque light blue colored cap and Opaque white colored body imprinted "SG" on cap and "115" on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-115-30
Strength 40 mg
Description of pill White to Off white powder filled in Hard Gelatin Capsules Size "0" with Opaque light blue colored cap and Opaque white colored body imprinted "SG" on cap and "115" on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-114-10
Strength 20 mg
Description of pill White to Off white powder filled in Empty Hard Gelatin Capsule Size 2, Opaque Light Blue Colored Cap and Opaque Light Green Colored, Body imprinted with 'SG' on Cap and "114" on Body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-114-01
Strength 20 mg
Description of pill White to Off white powder filled in Empty Hard Gelatin Capsule Size 2, Opaque Light Blue Colored Cap and Opaque Light Green Colored, Body imprinted with 'SG' on Cap and "114" on Body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-113-01
Strength 10 mg
Description of pill White to Off white powder filled in Empty Hard Gelatin Capsule Size 4, Opaque Light Blue Colored Cap and Opaque Light Orange Colored Body imprinted with "SG" on Cap and "113" on Body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Carisoprodol Tablets, USP

NDC 50228-109-01
Strength 350 mg
Description of pill Round convex white tablets
de-bossed with SG 109 on one side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Muscle relaxant
Brand Name Reference Soma®
TE Code AA

Ethacrynic acid Tablets, USP

NDC 50228-334-01
Strength 25 mg
Description of pill White Capsule shaped, Scored Tablets, de bossed with SG on one side with score line and 334 on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Diuretic (Treatment of edema)
Brand Name Reference Edecrin®
TE Code AB

Clopidogrel Tablets, USP

NDC 50228-124-10
Strength 75 mg
Description of pill Pink colored, Round shaped, Bi convex film coated tablets de-bossed on one side with 'SG' and '124' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Antiplatelet
Brand Name Reference Plavix®
TE Code AB

Clopidogrel Tablets, USP

NDC 50228-124-05
Strength 75 mg
Description of pill Pink colored, Round shaped, Bi convex film coated tablets de-bossed on one side with 'SG' and '124' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Antiplatelet
Brand Name Reference Plavix®
TE Code AB

Clopidogrel Tablets, USP

NDC 50228-124-90
Strength 75 mg
Description of pill Pink colored, Round shaped, Bi convex film coated tablets de-bossed on one side with 'SG' and '124' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Antiplatelet
Brand Name Reference Plavix®
TE Code AB

Clopidogrel Tablets, USP

NDC 50228-124-30
Strength 75 mg
Description of pill Pink colored, Round shaped, Bi convex film coated tablets de-bossed on one side with 'SG' and '124' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Antiplatelet
Brand Name Reference Plavix®
TE Code AB

Carisoprodol Tablets, USP

NDC 50228-109-10
Strength 350 mg
Description of pill Round convex white tablets
de-bossed with SG 109 on one side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Muscle relaxant
Brand Name Reference Soma®
TE Code AA

Carisoprodol Tablets, USP

NDC 50228-109-05
Strength 350 mg
Description of pill Round convex white tablets
de-bossed with SG 109 on one side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Muscle relaxant
Brand Name Reference Soma®
TE Code AA

Naproxen Sodium Tablets, USP

NDC 50228-433-05
Strength 550 mg(EQ 500 mg base)
Description of pill White, capsule shaped, film coated tablets, debossed with '433' on one side and 'SG' along with break line on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Anaprox DS®
TE Code AB

Pregabalin Capsules

NDC 50228-352-90
Strength 75 mg
Description of pill White to Off white powder filled in size"4" hard gelatin capsules with orange opaque colored cap and white opaque colored body imprinted with "SG" on cap and"352" on the body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anticonvulsant/Analgesics/Fibromyalgia
Brand Name Reference Lyrica®
TE Code AB

Metformin Hydrochloride Extended-Release Tablets, USP

NDC 50228-0504-60
Strength 1000 mg
Description of pill White to off white, oval shape, film coated tablets, debossed with “504” on one side and plain on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Fortamet®
TE Code AB

Levetiracetam Extended Release Tablets, USP

NDC 50228-189-60
Strength 500 mg
Description of pill White to off white, Oval shape tablets debossed ‘SG’ on one side and ‘189’ on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of partial-onset seizures
Brand Name Reference KEPPRA XR®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-128-90
Strength 0.5 mg
Description of pill White to off white, oval, flat, beveled edge uncoated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '28' on the other side. the right side of the bisect
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-127-10
Strength 0.25 mg
Description of pill White to off white, oval, flat, beveled edge un coated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '27' on the right side of the bisect
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-127-90
Strength 0.25 mg
Description of pill White to off white, oval, flat, beveled edge un coated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '27' on the right side of the bisect
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-126-10
Strength 0.125 mg
Description of pill White to off white, round, flat, beveled edge uncoated tablets, debossed with 'SG' on one side '126' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-126-90
Strength 0.125 mg
Description of pill White to off white, round, flat, beveled edge uncoated tablets, debossed with 'SG' on one side '126' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Levetiracetam Extended Release Tablets, USP

NDC 50228-190-60
Strength 750 mg
Description of pill White to off white, Oval shape tablets debossed SG on one side and 190 on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of partial-onset seizures
Brand Name Reference KEPPRA XR®
TE Code AB

Hydralazine Hydrochloride Tablets

NDC 50228-185-01
Strength 100 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “185” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Pramipexole Dihydrochloride Tablets

NDC 50228-129-90
Strength 0.75 mg
Description of pill White to off white, oval, flat, beveled edge uncoated tablets, debossed with 'SG' on one side '129' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Hydralazine Hydrochloride Tablets

NDC 50228-184-10
Strength 50 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “184” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Hydralazine Hydrochloride Tablets

NDC 50228-184-01
Strength 50 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “184” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Hydralazine Hydrochloride Tablets

NDC 50228-183-10
Strength 25 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “183” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Hydralazine Hydrochloride Tablets

NDC 50228-183-01
Strength 25 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “183” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Hydralazine Hydrochloride Tablets

NDC 50228-182-10
Strength 10 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “182” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Hydralazine Hydrochloride Tablets

NDC 50228-182-01
Strength 10 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “182” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Gabapentin Capsules, USP

NDC 50228-180-10
Strength 300 mg
Description of pill White to off white powder filled in size “1” hard gelatin capsules with opaque Yellow colored cap and opaque Yellow colored body imprinted “SG” on cap and “180” on body with black ink
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-128-10
Strength 0.5 mg
Description of pill White to off white, oval, flat, beveled edge uncoated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '28' on the other side. the right side of the bisect
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-129-10
Strength 0.75 mg
Description of pill White to off white, oval, flat, beveled edge uncoated tablets, debossed with 'SG' on one side '129' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Ezetimibe Tablets, USP

NDC 50228-379-05
Strength 10 mg
Description of pill White to off white, Capsule shaped tablets embossed with “SG” on one side and “379” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Anti-Hyperlipidemia
Brand Name Reference ZETIA®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-459-01
Strength 25/250 mg
Description of pill Light blue, Mottled, round, uncoated tablets debossed with "SG" on one side and ''459'' on the other
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Carbidopa and Levodopa Extended-Release Tablets , USP

NDC 50228-0461-10
Strength 50/200MG
Description of pill Light blue Mottled, oval, uncoated tablets debossed with ‘SG’ on one side and ‘461’on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET CR®
TE Code AB

Carbidopa and Levodopa Extended-Release Tablets , USP

NDC 50228-0461-01
Strength 50/200MG
Description of pill Light blue Mottled, oval, uncoated tablets debossed with ‘SG’ on one side and ‘461’on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET CR®
TE Code AB

Carbidopa and Levodopa Extended-Release Tablets , USP

NDC 50228-0460-10
Strength 25/100MG
Description of pill Light blue Mottled, oval, uncoated tablets debossed with ‘SG’ on one side and ‘460’on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET CR®
TE Code AB

Carbidopa and Levodopa Extended-Release Tablets , USP

NDC 50228-0460-01
Strength 25/100MG
Description of pill Light blue Mottled, oval, uncoated tablets debossed with ‘SG’ on one side and ‘460’on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET CR®
TE Code AB

Metformin Hydrochloride Extended-Release Tablets, USP

NDC 50228-446-90
Strength 1000 mg
Description of pill White to off white, oval shaped, biconvex tablets debossed with S on the left side of bisect and G on the right side of bisect and other side I on the left sideand 07 on the right side of the bisect..
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glumetza®
TE Code AB

Metformin Hydrochloride Extended-Release Tablets, USP

NDC 50228-445-01
Strength 500 mg
Description of pill White to off white, oval shape, film coated tablets, debossed with “445” on one side and plain on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glumetza®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-459-05
Strength 25/250 mg
Description of pill Light blue, Mottled, round, uncoated tablets debossed with "SG" on one side and ''459'' on the other
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-458-10
Strength 25/100 mg
Description of pill Light yellow, Mottled, round, uncoated tablets debossed with "SG" on one side and ''458'' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-130-90
Strength 1 mg
Description of pill White to off white, oval, flat, beveled edge un coated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '30' on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-458-05
Strength 25/100 mg
Description of pill Light yellow, Mottled, round, uncoated tablets debossed with "SG" on one side and ''458'' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-458-01
Strength 25/100 mg
Description of pill Light yellow, Mottled, round, uncoated tablets debossed with "SG" on one side and ''458'' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-457-05
Strength 10/100 mg
Description of pill Light blue, Mottled, round, uncoated tablets debossed with "SG" on one side and ''457'' on the other
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-457-01
Strength 10/100 mg
Description of pill Light blue, Mottled, round, uncoated tablets debossed with "SG" on one side and ''457'' on the other
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-131-10
Strength 1.5 mg
Description of pill White to off white, oval, flat, beveled edge un coated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '31' on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-131-90
Strength 1.5 mg
Description of pill White to off white, oval, flat, beveled edge un coated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '31' on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-130-10
Strength 1 mg
Description of pill White to off white, oval, flat, beveled edge un coated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '30' on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-179-10
Strength 100 mg
Description of pill White to Off white powder filled in size “3” hard gelatin capsules with opaque White colored cap and opaque White colored body imprinted “SG” on cap and “179” on body with black ink
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Ezetimibe Tablets, USP

NDC 50228-379-90
Strength 10 mg
Description of pill White to off white, Capsule shaped tablets embossed with “SG” on one side and “379” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Anti-Hyperlipidemia
Brand Name Reference ZETIA®
TE Code AB

Pregabalin Capsules

NDC 50228-351-90
Strength 50 mg
Description of pill White to Off white powder filled in size 3 hard gelatin capsules with white opaque colored cap and white opaque colored body imprinted with "SG" on cap and "351" on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anticonvulsant/Analgesics/Fibromyalgia
Brand Name Reference Lyrica®
TE Code AB

Quetiapine Extended-Release Tablets, USP

NDC 50228-0383-60
Strength 300 mg
Description of pill Pale yellow, film coated, capsule shaped biconvex tablet embossing with 383 on one side and plain on the other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic category Treatment of schizophrenia
Brand Name Reference Seroquel XR®
TE Code AB

Solifenacin Succinate Tablets

NDC 50228-428-30
Strength 10 mg
Description of pill Light Pink,Round Shape, film coated tablets, debossed with ' SG ' on one side '428' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Antimuscarinics
Brand Name Reference Vesicare®
TE Code AB

Solifenacin Succinate Tablets

NDC 50228-427-90
Strength 5 mg
Description of pill Light Yellow, Round Shape, film coated tablets, debossed with ' SG ' on one side '427' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Antimuscarinics
Brand Name Reference Vesicare®
TE Code AB

Solifenacin Succinate Tablets

NDC 50228-427-30
Strength 5 mg
Description of pill Light Yellow,Round Shape, film coated tablets, debossed with ' SG ' on one side '427' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Antimuscarinics
Brand Name Reference Vesicare®
TE Code AB

Ranolazine extended-release Tablets

NDC 50228-424-60
Strength 1000 mg
Description of pill Pale yellow, oblong shaped, film-coated, extended release tablet debossed with “424” on one side and “SG” on the other side
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic category Treatment of chronic angina
Brand Name Reference Ranexa®
TE Code AB

Ranolazine extended-release Tablets

NDC 50228-423-60
Strength 500 mg
Description of pill Peach, oblong shaped, film-coated, extended release tablet debossed with “423” on one side and “SG” on the other side
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic category Treatment of chronic angina
Brand Name Reference Ranexa®
TE Code AB

Quetiapine Extended-Release Tablets, USP

NDC 50228-0384-60
Strength 400 mg
Description of pill White, film coated, capsule shaped biconvex tablet embossing with 384 on one side and plain on the other side
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic category Treatment of schizophrenia
Brand Name Reference Seroquel XR®
TE Code AB

Quetiapine Extended-Release Tablets, USP

NDC 50228-0382-60
Strength 200 mg
Description of pill Yellow, film coated, capsule shaped biconvex tablet embossing with 382 on one side and plain on the other side
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic category Treatment of schizophrenia
Brand Name Reference Seroquel XR®
TE Code AB

Olmesartan Medoxomil Tablets 5 mg

NDC 50228-339-30
Strength 5 mg
Description of pill Yellow, round, film-coated, tablet debossed with SG on one side and 339 on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention -Angiotensin - II Receptor Blockers
Brand Name Reference Lipitor®
TE Code AB

Quetiapine Extended-Release Tablets, USP

NDC 50228-0381-60
Strength 150 mg
Description of pill White to off white, Capsule shaped biconvex tablets embossed with "381" on one side and plain on the other side
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic category Treatment of schizophrenia
Brand Name Reference Seroquel XR®
TE Code AB

Quetiapine Extended-Release Tablets, USP